Yan Chen
Shijiazhuang Yiling Pharmaceutical (China)(CN)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, Ferroptosis and cancer prognosis, Circular RNAs in diseases, RNA modifications and cancer, MicroRNA in disease regulation
Most-Cited Works
- → Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer(2015)615 cited
- → CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors(2014)432 cited
- → Three distinct signalling responses by murine fibroblasts to genotoxic stress(1996)358 cited
- → Analytical methods for physicochemical characterization of antibody drug conjugates(2011)356 cited
- → Characterizing dedifferentiation of thyroid cancer by integrated analysis(2021)167 cited
- → Notch signaling in lung diseases: focus on Notch1 and Notch3(2016)116 cited
- → Metagenomic next-generation sequencing for the clinical diagnosis and prognosis of acute respiratory distress syndrome caused by severe pneumonia: a retrospective study(2020)102 cited
- → Laparoscopy-assisted gastrectomy versus open gastrectomy for resectable gastric cancer: an update meta-analysis based on randomized controlled trials(2013)100 cited
- → The p53 tumor suppressor targets a novel regulator of G protein signaling(1997)97 cited
- → LncRNA TUG1 promotes cells proliferation and inhibits cells apoptosis through regulating AURKA in epithelial ovarian cancer cells(2018)78 cited